News

On the evening of December 7, 2024, the second Gala "Seeds of Aspiration" was successfully held at the Military Broadcasting and Television Center. During the event, the organizers announced and awarded the decision to support 100% of the costs for In Vitro Fertilization (IVF) under the program "Support for Infertile Soldiers - Love Spreads" for 2024 to 10 families of infertile soldiers.

Currently, the demand for Preimplantation Genetic Testing (PGT) among couples at high genetic risk, who wish to have healthy children, is increasing. Preimplantation Genetic Testing (PGT) was developed to screen and detect genetic abnormalities in embryos before they are implanted into the mother’s uterus.

With the aims to help doctors and experts in the assisted reproductive field update latest knowledge and information on the applications of PGT, GENTIS had held the science symposium with the theme “PGT genetic testing counseling: From international guidelines to clinical practice in Vietnam” at Equatorial Hotel, 242 Tran Binh Trong Street, Ward 4, District 5, Ho Chi Minh City.

During her visit to Vietnam, Professor Francesca Spinella (Senior Medical Information Specialist at Eurofins Genoma Group and Senior Expert Advisor to GENTIS) engaged in a series of significant activities at GENTIS and with partner institutions, including Hanoi’s Infertility and Andrology Hospital, Hanoi General Hospital, and Lac Viet Friendship Hospital. These expert meetings concluded successfully, laying the foundation for deeper, future collaboration between GENTIS, Genoma, and the partner hospitals.

On the morning of December 17, Genetic Testing Service Joint Stock Company (GENTIS) was honored by the Hanoi Tax Department as an outstanding tax-paying enterprise in the capital in 2023.

Genetic tests play a crucial role in determining infertility causes and assisted reproduction treatments. In Vietnam, GENTIS has acquired many achievements in researching and developing advanced genetic tests, positively benefiting the patients as well as enhancing the effectiveness in assisted reproductive treatments.

Newborn screening is a test conducted to detect conditions that may affect a child's physical and mental health and development in the future. Let’s explore 5 types of diseases that can be detected early through newborn screening.

On December 8, 2024, the 5th annual scientific conference HASAM 2024 with the theme “Updates on advanced in science and technology to enhance the effectiveness of infertility treatment”, organized by the Hanoi Assisted Reproductive Support Association (HASAR) was successfully held at the Pullman hotel, Hanoi. GENTIS was honored to be a sponsor and have a booth showcasing solutions for improving the effectiveness of reproductive support.